Week in Review: FDA OKs First Drug to Delay Type 1 Diabetes, Low-Protein Diet Linked to Obesity, and More
SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks - The Lancet Diabetes & Endocrinology
Jardiance (empagliflozin) for the Treatment of Type 2 Diabetes - Clinical Trials Arena
Lexicon Fires Back after Sanofi Ends Up-to-$1.7B Diabetes Collaboration
Biology | Free Full-Text | Differential Effects of Empagliflozin on Microvascular Complications in Murine Models of Type 1 and Type 2 Diabetes
FDA advisory committee rejects recommending approval of lower-dose empagliflozin for type 1 diabetes
US FDA issues CRL for empagliflozin for adults with type 1 diabetes
FDA Approves Jardiance to Treat Cardiovascular Disease in Diabetes Patients
SGLT-1/2-Hemmer auch bei Typ-1-Diabetes? - Der niedergelassene Arzt
.png "A Pill for Type 1 Diabetes? Two New Studies Investigate SGLT-2 Inhibitor Jardiance")
A Pill for Type 1 Diabetes? Two New Studies Investigate SGLT-2 Inhibitor Jardiance
Type 1 Diabetes - News, Articles etc. - European Pharmaceutical Review
U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® ( empagliflozin)
FDA rejects lower-dose empagliflozin 2.5 mg for type 1 diabetes
FDA approves Jardiance® (empagliflozin) tablets for adults with type 2 diabetes | Eli Lilly and Company
Frontiers | Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
FDA says no to Lilly, Boehringer's Jardiance in type 1 diabetes - PMLiVE
Missouri Society of Health-System Pharmacists - Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and their role in Type 1 Diabetes
FDA erweitert Zulassung: Empagliflozin-Patienten leben länger
US FDA approves Jardiance® (empagliflozin) to treat adults living with heart failure with reduced ejection fraction
FDA advisors say no to empagliflozin in type 1 diabetes - PMLiVE
SGLT2 Drug for T1D Gets Thumbs Down From FDA Panel | MedPage Today
FDA Approves Diabetes Medication for Heart Failure - Diabetes Education Services
10 Diabetes Medications That Cause Weight Gain (or Loss) - GoodRx
FDA approves empagliflozin to reduce CV death, HF hospitalization in HFpEF
FDA approves first triple combination pill for type 2 diabetes
SGLT2 inhibitors – moving on with the evidence - DiabetesontheNet
U.S. FDA approves Synjardy® (empagliflozin/metformin hydrochloride) tablets for adults with type 2 diabetes
